Posts Tagged: "ERS"

Biotech firms form patent alliance over interference proceeding against CRISPR patent application

The alliance is composed of firms that have a vested interest in the outcomes of a CRISPR patent interference case currently in front of the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board (PTAB). The interference proceeding specifically involves patents covering CRISPR/Cas9 gene editing technologies. The companies joining the alliance include Ireland-based ERS Genomics and Switzerland’s CRISPR Therapeutics (NASDAQ:CRSP) along with American biotech firms Caribou Biosciences and Intellia Therapeutics (NASDAQ:NTLA). These companies have all licensed CRIPSR/Cas9 technologies

Steve Brachmann

January 5, 2017

Posts Tagged: "ERS"

Varsity Sponsors

Latest IPW Posts

FTC Sets Meeting to Vote on Final Noncompete Rule

Commerce Department Opens $54 Million Funding Opportunity to Small Business R&D in Semiconductor Metrology

Timberland Loses Fourth Circuit Bid to Protect Trade Dress for Iconic Boots

Newman’s Counsel Says Supreme Court’s Agreement with Her Dissent Proves Mental Fitness

From Foundation to Fortress: Developing an IP Strategy for Success

IPWatchdog Events

Webinar: Benchmarking the Value of IP – How In-house and Outside Counsel Measure Efficacy and Impact

Webinar – Sponsored by Quartz IP

Patent Litigation Masters™ 2024

Webinar – Sponsored by LexisNexis

Webinar – Sponsored by Anaqua

From IPWatchdog